| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |